Clover Health Investments, Corp.
US ˙ NasdaqGS ˙ US18914F1030

SecurityCLOV / Clover Health Investments, Corp.
InstitutionAtom Investors LP
Latest Disclosed Ownership254,959 shares
Latest Disclosed Value $ 448,728
Atom Investors LP reports 393.38% increase in ownership of CLOV / Clover Health Investments, Corp.

On May 15, 2026 - Atom Investors LP filed a 13F-HR form disclosing ownership of 254,959 shares of Clover Health Investments, Corp. (US:CLOV) valued at $448,728 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 51,676 shares of Clover Health Investments, Corp.. This represents a change in shares of 393.38% during the quarter. The current value of the position is $930,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 254,959 203,283 393.38 449 270.25 0.0321
2026-02-17 2025-12-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 51,676 -774,915 -93.75 121 -95.22 0.0096
2025-11-14 2025-09-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 826,591 826,591 2,529 0.1918
2024-08-14 2024-06-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 0 -468,335 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 468,335 174,809 59.55 372 32.97 0.0464
2024-02-14 2023-12-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 293,526 202,859 223.74 279 187.63 0.0494
2023-11-14 2023-09-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 90,667 -205,107 -69.35 98 -63.40 0.0223
2023-08-14 2023-06-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 295,774 252,480 583.18 265 636.11 0.1007
2023-05-15 2023-03-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 43,294 -23,188 -34.88 37 -40.98 0.0199
2023-02-14 2022-12-31 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 66,482 66,482 62 0.0309
2021-11-15 2021-09-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 0 -208,969 -100.00 0 -100.00
2021-08-16 2021-06-30 13F CLOVER HEALTH INVESTMENTS COM CL A 18914F103 208,969 208,969 2,783 0.3501
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.